Free Trial

Avanos Medical (AVNS) Stock Price, News & Analysis

Avanos Medical logo
$11.93 +0.06 (+0.54%)
Closing price 03:59 PM Eastern
Extended Trading
$11.92 -0.01 (-0.08%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Avanos Medical Stock (NYSE:AVNS)

Key Stats

Today's Range
$11.73
$11.97
50-Day Range
$9.98
$12.50
52-Week Range
$9.30
$25.36
Volume
647,282 shs
Average Volume
541,221 shs
Market Capitalization
$553.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Avanos Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

AVNS MarketRank™: 

Avanos Medical scored higher than 68% of companies evaluated by MarketBeat, and ranked 320th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Avanos Medical are expected to grow by 31.06% in the coming year, from $1.32 to $1.73 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avanos Medical is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avanos Medical is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Avanos Medical has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Avanos Medical's valuation and earnings.
  • Percentage of Shares Shorted

    4.23% of the float of Avanos Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avanos Medical has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Avanos Medical has recently increased by 25.83%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Avanos Medical does not currently pay a dividend.

  • Dividend Growth

    Avanos Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.23% of the float of Avanos Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avanos Medical has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Avanos Medical has recently increased by 25.83%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Avanos Medical has a news sentiment score of 1.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Avanos Medical this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for AVNS on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Avanos Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $659,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 2.64% of the stock of Avanos Medical is held by insiders.

  • Percentage Held by Institutions

    95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Avanos Medical's insider trading history.
Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AVNS Stock News Headlines

The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
See More Headlines

AVNS Stock Analysis - Frequently Asked Questions

Avanos Medical's stock was trading at $15.92 at the beginning of the year. Since then, AVNS shares have decreased by 25.6% and is now trading at $11.8450.

Avanos Medical, Inc. (NYSE:AVNS) released its quarterly earnings results on Tuesday, August, 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by $0.01. The business had revenue of $175 million for the quarter, compared to the consensus estimate of $165.50 million. Avanos Medical had a negative net margin of 66.89% and a positive trailing twelve-month return on equity of 6.16%.
Read the conference call transcript
.

Top institutional shareholders of Avanos Medical include Armistice Capital LLC (4.39%), Brown Advisory Inc. (3.90%), Paradice Investment Management LLC (2.71%) and Geode Capital Management LLC (2.31%). Insiders that own company stock include Michael Greiner, Gary Blackford, Kerr Holbrook and Julie Ann Shimer.
View institutional ownership trends
.

Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avanos Medical investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Home Depot (HD), Netflix (NFLX) and Tesla (TSLA).

Company Calendar

Last Earnings
8/05/2025
Today
8/29/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:AVNS
CIK
1606498
Fax
N/A
Employees
2,227
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($10.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
8.96
P/E Growth
N/A
Net Income
-$392.10 million
Net Margins
-66.89%
Pretax Margin
-68.91%
Return on Equity
6.16%
Return on Assets
4.57%

Debt

Debt-to-Equity Ratio
0.12
Current Ratio
2.64
Quick Ratio
1.58

Sales & Book Value

Annual Sales
$687.80 million
Price / Sales
0.80
Cash Flow
$11.83 per share
Price / Cash Flow
1.00
Book Value
$16.73 per share
Price / Book
0.71

Miscellaneous

Outstanding Shares
46,400,000
Free Float
45,177,000
Market Cap
$548.91 million
Optionable
Optionable
Beta
1.12

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:AVNS) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners